Europe
ODDO SEYDLER BANK AG will henceforth be the second Designated Sponsor of Expedeon AG’s share, as Expedeon announced.
Probiodrug AG, announced that with entry into the commercial register Stendal the Company has now officially changed its name to Vivoryon Therapeutics AG as of June 11, 2019.
Companies from across the globe share business and pipeline updates.
The funds raised will take the company through the end of 2020. The company plans to have a product on the market in 2021, if all goes well.
Novartis was alleged to have held about 80,000 sham events where doctors were wined and dined in order to boost sales of key medications.
Patients receiving Cosentyx showed no radiographic progression in almost 90% of PsA patients over two years. Of the patients receiving the drug at 150 mg, 66.3% had rapid and significant improvements in symptoms of the disease with axial manifestations at week 12.
Almost 15,000 physicians, scientists, health care professionals and industry representatives from around the globe presented research, treatment recommendations and advances toward a diabetes cure at the American Diabetes Association’s 79th Scientific Sessions in San Francisco this week.
Aspera, the leading provider of solutions and services for Software Asset Management, announced the signing of a 3 year contract for delivery managed services to a enterprise that figures among the top 5 pharmaceutical companies in the world.
The Dutch company Xenikos B.V. announced that the U.S. Food and Drug Administration has approved an investigational new drug application to initiate a U.S.-based clinical Phase 3 registration trial in order to test the efficacy of T-Guard for treating steroid-refractory acute graft-versus-host disease in patients following allogeneic stem cell transplantation.
Heidelberg Pharma AG announced that they will present their proprietary technology for Antibody Targeted Amanitin Conjugates as potential therapeutic modality for cancer therapy at two upcoming scientific conferences.
PRESS RELEASES